clinical trial · NCT04976868
Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis
Atopic DermatitisPimecrolimus 1% Top Cream
brief summary
The primary objective of the present multicentre, prospective, non-interventional study (NIS) is gathering knowledge on the actual use and effectiveness of Elidel® in Chinese patients with mild to moderate AD affecting sensitive skin areas in routine clinical practice.
started
Mar 18, 2021
primary completion
Oct 31, 2022
completion
Oct 31, 2022
last updated
May 24, 2023
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol